Bayer investor Jeff Ubben has contacted fellow shareholders in the German group, investors and sources familiar with the matter told Reuters, in an apparent attempt to rally support for big changes at the drugs-to-pesticides company.
Posts
The company is facing demands from activist investor Bluebell Capital Partners to break up, according to a source familiar with the matter, pushing shares in the diversified health and agriculture group to a five-week high.